145 related articles for article (PubMed ID: 17111390)
1. Lessons from the old masters: pragmatism or purity, FDG PET SUV, serum glucose and prediction of nodal status in non-small cell lung cancer.
Akhurst T
J Surg Oncol; 2006 Dec; 94(7):547-8. PubMed ID: 17111390
[No Abstract] [Full Text] [Related]
2. Standard uptake value predicts survival in non-small cell lung cancer.
Okereke IC; Gangadharan SP; Kent MS; Nicotera SP; Shen C; DeCamp MM
Ann Thorac Surg; 2009 Sep; 88(3):911-5; discussion 915-6. PubMed ID: 19699919
[TBL] [Abstract][Full Text] [Related]
3. 18F-FDG PET for mediastinal staging of lung cancer: which SUV threshold makes sense?
Hellwig D; Graeter TP; Ukena D; Groeschel A; Sybrecht GW; Schaefers HJ; Kirsch CM
J Nucl Med; 2007 Nov; 48(11):1761-6. PubMed ID: 17942814
[TBL] [Abstract][Full Text] [Related]
4. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study.
Higashi K; Ito K; Hiramatsu Y; Ishikawa T; Sakuma T; Matsunari I; Kuga G; Miura K; Higuchi T; Tonami H; Yamamoto I
J Nucl Med; 2005 Feb; 46(2):267-73. PubMed ID: 15695786
[TBL] [Abstract][Full Text] [Related]
6. Relationship between primary tumor fluorodeoxyglucose uptake and nodal or distant metastases at presentation in T1 stage non-small cell lung cancer.
Li M; Liu N; Hu M; Shi F; Yuan S; Zhang P; Fu Z; Yang G; Yu J
Lung Cancer; 2009 Mar; 63(3):383-6. PubMed ID: 18635284
[TBL] [Abstract][Full Text] [Related]
7. Integrated FDG-PET/CT does not make invasive staging of the intrathoracic lymph nodes in non-small cell lung cancer redundant: a prospective study.
Tournoy KG; Maddens S; Gosselin R; Van Maele G; van Meerbeeck JP; Kelles A
Thorax; 2007 Aug; 62(8):696-701. PubMed ID: 17687098
[TBL] [Abstract][Full Text] [Related]
8. Sensitive detection of mediastinal lymph node metastasis of lung cancer with 11C-choline PET.
Hara T; Inagaki K; Kosaka N; Morita T
J Nucl Med; 2000 Sep; 41(9):1507-13. PubMed ID: 10994730
[TBL] [Abstract][Full Text] [Related]
9. Consideration of serum glucose levels during malignant mediastinal lymph node detection in non-small-cell lung cancer by FDG-PET.
Lee WW; Chung JH; Jang SJ; Eo JS; Park SY; Sung SW; So Y; Chung JK; Lee MC; Kim SE
J Surg Oncol; 2006 Dec; 94(7):607-13. PubMed ID: 17039492
[TBL] [Abstract][Full Text] [Related]
10. Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.
Steinert HC; Hauser M; Allemann F; Engel H; Berthold T; von Schulthess GK; Weder W
Radiology; 1997 Feb; 202(2):441-6. PubMed ID: 9015071
[TBL] [Abstract][Full Text] [Related]
11. Radioguided detection of lymph node metastasis in non-small cell lung cancer.
Nwogu C; Fischer G; Tan D; Glinianski M; Lamonica D; Demmy T
Ann Thorac Surg; 2006 Nov; 82(5):1815-20; discussion 1820. PubMed ID: 17062254
[TBL] [Abstract][Full Text] [Related]
12. Dual-time-point FDG-PET for evaluation of lymph node metastasis in patients with non-small-cell lung cancer.
Nishiyama Y; Yamamoto Y; Kimura N; Ishikawa S; Sasakawa Y; Ohkawa M
Ann Nucl Med; 2008 May; 22(4):245-50. PubMed ID: 18535874
[TBL] [Abstract][Full Text] [Related]
13. Prognostic stratification of stage IIIA-N2 non-small-cell lung cancer after induction chemotherapy: a model based on the combination of morphometric-pathologic response in mediastinal nodes and primary tumor response on serial 18-fluoro-2-deoxy-glucose positron emission tomography.
Dooms C; Verbeken E; Stroobants S; Nackaerts K; De Leyn P; Vansteenkiste J
J Clin Oncol; 2008 Mar; 26(7):1128-34. PubMed ID: 18309948
[TBL] [Abstract][Full Text] [Related]
14. Increased standardized uptake value in the primary lesion predicts nodal or distant metastases at presentation in lung cancer.
Sachs S; Bilfinger TV; Komaroff E; Franceschi D
Clin Lung Cancer; 2005 Mar; 6(5):310-3. PubMed ID: 15845183
[TBL] [Abstract][Full Text] [Related]
15. Sentinel node and positron emission tomography mapping in lung cancer.
Nwogu C
Semin Thorac Cardiovasc Surg; 2009; 21(4):323-6. PubMed ID: 20226345
[TBL] [Abstract][Full Text] [Related]
16. [Preliminary study of 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients].
Liu LP; Yu JM; Guo HB; Fu Z; Han AQ; Yang GR
Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):453-6. PubMed ID: 17974282
[TBL] [Abstract][Full Text] [Related]
17. FDG-PET for lymph node staging in NSCLC: a major step forward, but beware of the pitfalls.
Vansteenkiste JF
Lung Cancer; 2005 Feb; 47(2):151-3. PubMed ID: 15639713
[No Abstract] [Full Text] [Related]
18. The standardize uptake value: light and shade of positron emission tomography.
Bertolaccini L; Rizzardi G; Terzi A; Bianchi A
Interact Cardiovasc Thorac Surg; 2011 Jun; 12(6):969. PubMed ID: 21659322
[No Abstract] [Full Text] [Related]
19. Maximum standard uptake value of mediastinal lymph nodes on integrated FDG-PET-CT predicts pathology in patients with non-small cell lung cancer.
Bryant AS; Cerfolio RJ; Klemm KM; Ojha B
Ann Thorac Surg; 2006 Aug; 82(2):417-22; discussion 422-3. PubMed ID: 16863739
[TBL] [Abstract][Full Text] [Related]
20. Use of anthropometric factors in 18F-FDG PET bone marrow SUVs.
Thie JA
J Nucl Med; 2006 Nov; 47(11):1901-2; author reply 1902. PubMed ID: 17079825
[No Abstract] [Full Text] [Related]
[Next] [New Search]
